1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Global Tissue Diagnostics Market 2016-2020

Global Tissue Diagnostics Market 2016-2020

  • February 2016
  • -
  • Infiniti Research Limited
  • -
  • 72 pages

Summary

Table of Contents

Search Inside

About Tissue Diagnostics

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (ISH), immunohistochemistry (IHC), special staining, and digital pathology and related methods including core biopsy, fine needle aspiration cytology, and open biopsy to study and diagnose cells.

Technavio’s analysts forecast the global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global tissue diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:
- Advanced staining
- Preanalytical and routine staining
- Digital pathology


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Abbott Diagnostics
- Agilent Technologies (a parent company of Dako)
- Danaher (a parent company of Leica Biosystems)
- Roche Diagnostics


Other prominent vendors
- 20/20 GeneSystems
- Abcam
- AdnaGen
- Advanced Cell Diagnostics
- Affymetrix
- Agendia
- AutoGenomics
- AVIVA BioSciences
- Biocare Medical
- Biocartis
- Cancer Genetics
- ELITechGroup
- Enzo Biochem
- Epic Sciences
- Fluidigm
- HORIBA Medical
- Janssen Diagnostics
- Olympus Diagnostics Systems Group
- Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
- Oxford Gene Technology
- PANAGENE
- Protea Biosciences Group
- Sakura Finetek

Market driver
- Implementation by new customers
- For a full, detailed list, view our report

Market challenge
- Insurance coverage and reimbursement issues
- For a full, detailed list, view our report

Market trend
- Ready-to-use reagents
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics 2021: Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2021: Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


Download Unlimited Documents from Trusted Public Sources

Diagnostics Forecast in the US

  • March 2017
    2 pages
  • United States  

View report >

Diagnostics Markets in the US

  • March 2017
    3 pages
  • Diagnostics  

  • United States  

View report >

Diagnostics Forecast in the US

  • February 2017
    2 pages
  • Diagnostics  

    Cancer  

    Health Care Pro...  

  • United States  

View report >

Related Market Segments :

Diagnostics
Cancer
Lung Cancer

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.